451 related articles for article (PubMed ID: 20233997)
1. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.
Zhang J; Lu Y; Pienta KJ
J Natl Cancer Inst; 2010 Apr; 102(8):522-8. PubMed ID: 20233997
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
3. CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation.
Roca H; Varsos Z; Pienta KJ
J Biol Chem; 2008 Sep; 283(36):25057-73. PubMed ID: 18611860
[TBL] [Abstract][Full Text] [Related]
4. Indole-3-carbinol and 3',3'-diindolylmethane modulate androgen's effect on C-C chemokine ligand 2 and monocyte attraction to prostate cancer cells.
Kim EK; Kim YS; Milner JA; Wang TT
Cancer Prev Res (Phila); 2013 Jun; 6(6):519-29. PubMed ID: 23585426
[TBL] [Abstract][Full Text] [Related]
5. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
6. CCL2, survivin and autophagy: new links with implications in human cancer.
Roca H; Varsos ZS; Mizutani K; Pienta KJ
Autophagy; 2008 Oct; 4(7):969-71. PubMed ID: 18758234
[TBL] [Abstract][Full Text] [Related]
7. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling.
Hu WT; Li MQ; Liu W; Jin LP; Li DJ; Zhu XY
Mol Hum Reprod; 2014 Apr; 20(4):358-72. PubMed ID: 24344240
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA
Misawa A; Kondo Y; Takei H; Takizawa T
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33514011
[TBL] [Abstract][Full Text] [Related]
9. CCL2 is a potent regulator of prostate cancer cell migration and proliferation.
Loberg RD; Day LL; Harwood J; Ying C; St John LN; Giles R; Neeley CK; Pienta KJ
Neoplasia; 2006 Jul; 8(7):578-86. PubMed ID: 16867220
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone.
Kirk PS; Koreckij T; Nguyen HM; Brown LG; Snyder LA; Vessella RL; Corey E
Int J Mol Sci; 2013 May; 14(5):10483-96. PubMed ID: 23698775
[TBL] [Abstract][Full Text] [Related]
11. Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer.
Izumi K; Mizokami A; Lin HP; Ho HM; Iwamoto H; Maolake A; Natsagdorj A; Kitagawa Y; Kadono Y; Miyamoto H; Huang CK; Namiki M; Lin WJ
Oncotarget; 2016 Feb; 7(7):8389-98. PubMed ID: 26701731
[TBL] [Abstract][Full Text] [Related]
12. C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment.
Urata S; Izumi K; Hiratsuka K; Maolake A; Natsagdorj A; Shigehara K; Iwamoto H; Kadomoto S; Makino T; Naito R; Kadono Y; Lin WJ; Wufuer G; Narimoto K; Mizokami A
Cancer Sci; 2018 Mar; 109(3):724-731. PubMed ID: 29288523
[TBL] [Abstract][Full Text] [Related]
13. The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.
He S; He S; Chen CH; Deborde S; Bakst RL; Chernichenko N; McNamara WF; Lee SY; Barajas F; Yu Z; Al-Ahmadie HA; Wong RJ
Mol Cancer Res; 2015 Feb; 13(2):380-90. PubMed ID: 25312961
[TBL] [Abstract][Full Text] [Related]
14. Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.
Chiu HY; Sun KH; Chen SY; Wang HH; Lee MY; Tsou YC; Jwo SC; Sun GH; Tang SJ
Cytokine; 2012 Aug; 59(2):423-32. PubMed ID: 22617682
[TBL] [Abstract][Full Text] [Related]
15. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
16. RNAi targeting of CCR2 gene expression induces apoptosis and inhibits the proliferation, migration, and invasion of PC-3M cells.
Gao J; Wang A; Zhang M; Li H; Wang K; Han Y; Wang Z; Shi C; Wang W
Oncol Res; 2013; 21(2):73-82. PubMed ID: 24406043
[TBL] [Abstract][Full Text] [Related]
17. CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration.
Lin TH; Liu HH; Tsai TH; Chen CC; Hsieh TF; Lee SS; Lee YJ; Chen WC; Tang CH
Biochim Biophys Acta; 2013 Oct; 1830(10):4917-27. PubMed ID: 23845726
[TBL] [Abstract][Full Text] [Related]
18. Possible mechanism of CCL2-induced Akt activation in prostate cancer cells.
Mizutani K; Roca H; Varsos Z; Pienta KJ
Anticancer Res; 2009 Aug; 29(8):3109-13. PubMed ID: 19661323
[TBL] [Abstract][Full Text] [Related]
19. Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone.
Lu Y; Chen Q; Corey E; Xie W; Fan J; Mizokami A; Zhang J
Clin Exp Metastasis; 2009; 26(2):161-9. PubMed ID: 19002595
[TBL] [Abstract][Full Text] [Related]
20. Chemokine CCL2 enhances survival and invasiveness of endometrial stromal cells in an autocrine manner by activating Akt and MAPK/Erk1/2 signal pathway.
Li MQ; Li HP; Meng YH; Wang XQ; Zhu XY; Mei J; Li DJ
Fertil Steril; 2012 Apr; 97(4):919-29. PubMed ID: 22265030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
